The FBI Wants Speedy DNA Analysis Added To Its Biometric Dragnet
By Tim Cushing,
TechDirt
| 09. 30. 2014
Untitled Document
The FBI's Next Generation Identification (NGI) database has been discussed here several times, thanks to its "expeditious" blend of criminal and non-criminal data, its postponed-forever Privacy Impact Assessment the agency has been promising since 2008, the limited, four-state rollout of facial recognition software with a 20% error rate, and its peculiar exclusion of DOJ/law enforcement employees from its lifelong criminal database monitoring.
It appears the FBI isn't satisfied with the wealth of biometric information it already has access to. It's grabbed everything external it can possibly get (faces, distinctive marks, fingerprints, civil/criminal records, voice recordings, iris scans [coming soon!]). Now, it's coming for what's inside you.
The FBI is preparing to accelerate the collection of DNA profiles for the government's massive new biometric identification database.
Developers of portable DNA analysis machines have been invited to a Nov. 13 presentation to learn about the bureau's vision for incorporating their technology into the FBI's new database.
So-called rapid DNA systems can draw up a profile in about 90 minutes.
DNA has been an integral part of criminal investigations...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...